Evidence map›Paper›PMID 42121048›Full record

ArticleBMC nephrology2026

Distinct longitudinal trajectories of alkaline phosphatase and parathyroid hormone at dialysis initiation predict mortality in incident hemodialysis patients.

Chin-Wen Hsieh, Chien-Ching Li, Ping-Hsun Wu, Shih-Yuan Hung, Shih-Feng Weng, Chung-Hwan Chen, Mei-Ling Ho, Hung-Hsiang Liou

Abstract read
In one paragraph

Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chin-Wen HsiehDivision of Nephrology, Department of Internal Medicine, Pingtung Christian Hospital, Pingtung, Taiwan.
Chien-Ching LiDepartment of Health Systems Management, Rush University, Chicago, IL, USA.
Ping-Hsun WuFaculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Shih-Yuan HungSchool of Medicine, College of Medicine, Division of Nephrology, Department of Internal Medicine, I-Shou University, E-DA Hospital, Kaohsiung, Taiwan.
Shih-Feng WengDepartment of Healthcare Administration and Medical Informatics, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chung-Hwan ChenFaculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. hwan@kmu.edu.tw.
Mei-Ling HoRegenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan. homelin@kmu.edu.tw.
Hung-Hsiang LiouDivision of Nephrology, Department of Medicine, Hsin-Jen Hospital, New Taipei County, Taiwan.

Funding

Ping Tung Christian Hospital PS112009
6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD)-mineral and bone disorder (MBD) contributes to fractures, cardiovascular events, and mortality in patients receiving maintenance hemodialysis (MHD). The longitudinal patterns of the CKD-MBD biomarkers parathyroid hormone (PTH) and alkaline phosphatase (ALP), as well as their prognostic value, remain uncertain.

methodsWe retrospectively identified patients initiating MHD between 2004 and 2012 using linked medical records and Taiwan National Health Insurance Research Database. Two-year serial ALP (n = 447) and PTH (n = 338) measurements were analyzed using group-based trajectory modeling to characterize longitudinal patterns. A landmark design was applied for outcome analysis, and multivariable Cox models were used to assess associations between trajectory group membership and subsequent clinical outcomes, including fractures, major adverse cardiovascular events, cardiovascular death, and all-cause mortality.

resultsThree distinct trajectories were identified for both ALP and PTH, and remained stable from MHD initiation. ALP trajectories were labeled as low-normal, high-normal, and high based on median levels relative to the reference range, while PTH trajectories were labeled as below-target, within-lower-target, and within-upper-target according to KDIGO-recommended target ranges for patients receiving MHD; these groups demonstrated statistically significant differences in median ALP and PTH levels across trajectories. A high-normal ALP trajectory was independently associated with cardiovascular death (adjusted HR, 8.44; 95% CI, 1.78-39.96; P = 0.0072) and all-cause mortality (adjusted HR, 1.54; 95% CI, 1.15-2.06; P = 0.0034). A below-target PTH trajectory was associated with a higher crude risk of all-cause mortality compared with other trajectory patterns.

conclusionsALP and PTH trajectories are identifiable early after HD initiation and reflect distinct risk profiles. These findings support the clinical value of longitudinal monitoring from the early dialysis period and highlight the importance of avoiding PTH oversuppression to improve risk stratification and management. Future large-scale prospective studies are needed to clarify subtle longitudinal changes in ALP and PTH and their associations with outcomes.

Indexed as

Alkaline PhosphataseParathyroid HormoneRenal DialysisRenal Insufficiency, ChronicAgedBiomarkersChronic Kidney Disease-Mineral and Bone DisorderFemaleHumansLongitudinal StudiesMaleMiddle AgedPredictive Value of TestsPrognosisRetrospective StudiesTaiwanAlkaline PhosphataseBiomarkersParathyroid HormoneAlkaline phosphataseHemodialysisOutcomesParathyroid hormoneTrajectory

Identifiers

PMID42121048
PMCPMC13340355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.